HIV research: a need to focus on the right target

The Lancet

Volumn 345, Issue 8965, 1995, Pages 1619-1621

  Levy, J A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; VIRUS ANTIBODY;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY TITER; ANTIVIRAL ACTIVITY; CELLULAR IMMUNITY; DISEASE COURSE; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LATENT PERIOD; MEDICAL RESEARCH; PRIORITY JOURNAL; SHORT SURVEY; T LYMPHOCYTE; VACCINE PRODUCTION; VIRUS TRANSMISSION;

EID: 0029023727     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(95)90121-3     Document Type: Article

References (28)

1. Viral dynamics in human immunodeficiency virus type 1 infection
2. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection
3. Factors underlying spontaneous inactivation and susceptibility to neutralisation of human immunodeficiency virus
4. Enzymatic amplification of hepatitis B virus DNA in serum compared with infectivity testing in chimpanzees
5. The simian retroviruses: SIV and SRV
6. Massive cohort infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS
7. Quantitation of human immunodeficiency virus type 1 infection kinetics
8. The role of cell-to-cell transmission in HIV infection
9. Efficacy of nonoxynol 9 contraceptive sponge use in preventing heterosexual acquisition of HIV in Nairobi prostitutes
10. HIV: to vaccinate or not to vaccinate?
11. Downregulation of HLA class I antigens in HIV-1 infected cells
12. Cytotoxic T lymphocytes in HIV infection
13. Measuring vaccine-induced HIV neutralization: report of a workshop
14. Human trials of experimental AIDS vaccines
15. Properties of mouse leukemia viruses. IX. Active and passive immunization of mice against Friend leukemia with isolated viral gp71 glycoprotein and its corresponding antisera
16. Immunogenicity and efficacy of a commercial feline leukemia virus vaccine
17. Temporal association of cellular immune responses with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome
18. Non-cytolytic CD8 T-cell anti-HIV responses in primary infection
19. Vaccine protection of chimpanzees against challenge with HIV-1 1 infected peripheral blood mononuclear cells
20. Protection by attenuated simian immunodeficiency virus in macaques against challenge with virus-infected cells
21. Effect of zidovudine therapy on CD8+ T cell anti-HIV activity
22. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy
23. HIV pathogenesis and long-term survival
24. HIV-specific cytotoxic T-cells in HIV-exposed but uninfected Gambian women
25. The Thl-Th2 hypothesis of HIV infection new insights